Literature DB >> 6262367

Effects of exogenous beta h-endorphin on pituitary hormone secretion and its disappearance rate in normal human subjects.

R L Reid, J D Hoff, S S Yen, C H Li.   

Abstract

The disappearance rate of the immunoreactive beta h-endorphin and the effects of beta h-endorphin on pituitary hormone secretion were investigated in normal volunteers. Synthetic human beta h-endorphin was administered as a 2.5-mg iv bolus to five normal women resulting in a 1000-fold increase in concentration of circulating immunoreactive beta h-endorphin within 2.5 min. This was followed by a triple exponential disappearance curve yielding an initial fast component with a half-time (t 1/2; +/-SD) of 4.1 (+/-0.6) min, a midrange component with a t 1/2 of 13.1 (+/-0.6 min, and a slow component with t 1/2 of 46.2 (+/-7.0) min. In both male and female subjects this dose of beta-endorphin induced a significant increase in the levels of PRL and a significant decline in the concentration of LH, without altering basal levels of GH and TSH.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6262367     DOI: 10.1210/jcem-52-6-1179

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  The effects of prolonged opioidergic blockade on LH pulsatile secretion during the menstrual cycle.

Authors:  W G Rossmanith; U Wirth; K Sterzik; S S Yen
Journal:  J Endocrinol Invest       Date:  1989-04       Impact factor: 4.256

2.  Plasma levels of beta-endorphin, prolactin and gonadotropins in male athletes after an international nordic ski race.

Authors:  C Mougin; M T Henriet; A Baulay; D Haton; S Berthelay; R C Gaillard
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1988

Review 3.  Maternal and fetal beta endorphin: effects of pregnancy and labour.

Authors:  T K Abboud
Journal:  Arch Dis Child       Date:  1988-07       Impact factor: 3.791

4.  Effect of exogenously administered estrogens on luteinizing hormone release in a complete testicular feminization syndrome patient with very low testosterone levels, before and after gonadectomy.

Authors:  M Marcelli; I Nicoletti; M A Sansone; G P Reboldi; G Angeletti; F Santeusanio; P Brunetti
Journal:  J Endocrinol Invest       Date:  1987-08       Impact factor: 4.256

5.  Naloxone increases the response of growth hormone and prolactin to stimuli in obese humans.

Authors:  G Plewe; U Schneider; U Krause; J Beyer
Journal:  J Endocrinol Invest       Date:  1987-04       Impact factor: 4.256

6.  Stress hormones in accident patients studied before admission to hospital.

Authors:  W Hetz; H D Kamp; U Zimmermann; A von Bohlen; L Wildt; J Schuettler
Journal:  J Accid Emerg Med       Date:  1996-07

Review 7.  New concepts in the regulation of hypothalamic gonadotropin releasing hormone (GnRH) secretion.

Authors:  D D Rasmussen
Journal:  J Endocrinol Invest       Date:  1986-10       Impact factor: 4.256

8.  Endorphins and exercise.

Authors:  V J Harber; J R Sutton
Journal:  Sports Med       Date:  1984 Mar-Apr       Impact factor: 11.136

9.  Effects of naloxone on diurnal rhythms in mood and endocrine function: a dose-response study in man.

Authors:  A F Martin del Campo; J H Dowson; J Herbert; E S Paykel
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

10.  Resolution of anovulation infertility using neuro emotional technique: a report of 3 cases.

Authors:  Peter Bablis; Henry Pollard; Daniel A Monti
Journal:  J Chiropr Med       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.